moxisylyte has been researched along with Idiopathic Parkinson Disease in 1 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mai, J | 1 |
| Olsen, RB | 1 |
1 other study available for moxisylyte and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Depression of essential tremor by alpha-adrenergic blockade.
Topics: Humans; Moxisylyte; Parkinson Disease; Tremor | 1981 |